Featured Research

from universities, journals, and other organizations

Rapid rise in antipsychotic treatment of medicaid-insured children

Date:
March 15, 2013
Source:
University of Maryland
Summary:
More benefit/risk information is needed in community care efforts, says a researcher.

A new study from the University of Maryland (UM) found that use of antipsychotic drugs from 1997 to 2006 increased 7- to 12-fold in a Medicaid population of about 500,000 children ages two to 17.

Related Articles


The study, the latest to confirm a rapid rise of antipsychotics prescribed among Medicaid-insured children, raises questions about America's health care system, says lead author Julie Zito, PhD, professor in the UM School of Pharmacy.

"Many were diagnosed with behavioral rather than psychotic conditions for which they have FDA-approved labeling," says Zito. "These are often children with serious socio-economic and family life problems. We need more information on the benefits and risks of using antipsychotics for behavioral conditions, such as attention deficit hyperactivity disorder, ADHD, in community treated populations." Furthermore, use of antipsychotics in children with Medicaid coverage is five times that of children in the private sector -- a disparity in need of greater study.

The increased use of antipsychotic medication was most prominent among youths qualifying by low family income in the state Children's Health Insurance Program (SCHIP) or through very low income in the Temporary Assistance for Needy Families (TANF) assistance program. By contrast, there was less change among the most impaired and vulnerable youths -- those in foster care or those in the Supplemental Security Income (SSI) program, i.e. youth eligible because of disability.

Zito says, "It raises questions such as 'are the standard treatments for behavior conditions sufficiently evidence-based in community populations.' Outcomes research can answer these questions." The National Institutes of Health website defines outcomes research as actively engaging in research using existing national survey datasets, and also supports, develops, and analyzes additional targeted surveys.

The study also found that many of the children received just one or two prescriptions in the study year and then left treatment. "For a behavior problem, it means they just didn't come back, so there may be a continuity problem. This suggests we need more emphasis on uninterrupted community care. But unfortunately, we have a very disjointed heath care system."

The Medicaid data set was generated from a representative mid-Atlantic state. The study appears in the current issue of the journal Psychiatric Services, by Zito and graduate student Mehmet Burcu, MS, in the School of Pharmacy's Department of Pharmaceutical Health Services Research; Laurence S. Magder, PhD, professor and director of Biostatistics in the UM School of Medicine's, Department of Epidemiology and Public Health; Aloysius Ibe, DrPH, with the School of Community Health and Policy, Morgan State University; and Daniel J. Safer, MD, child psychiatrist with the Departments of Psychiatry and Pediatrics, Johns Hopkins University.


Story Source:

The above story is based on materials provided by University of Maryland. Note: Materials may be edited for content and length.


Cite This Page:

University of Maryland. "Rapid rise in antipsychotic treatment of medicaid-insured children." ScienceDaily. ScienceDaily, 15 March 2013. <www.sciencedaily.com/releases/2013/03/130315150855.htm>.
University of Maryland. (2013, March 15). Rapid rise in antipsychotic treatment of medicaid-insured children. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2013/03/130315150855.htm
University of Maryland. "Rapid rise in antipsychotic treatment of medicaid-insured children." ScienceDaily. www.sciencedaily.com/releases/2013/03/130315150855.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Science & Society News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Be Careful, April Fools' Day Is Alive And Well

Be Careful, April Fools' Day Is Alive And Well

Newsy (Apr. 1, 2015) You’re going to want to double-check anything you see on the Internet today. If it sounds too good or too weird to be true, it probably is. Video provided by Newsy
Powered by NewsLook.com
Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

AFP (Apr. 1, 2015) The governments of Liberia and Sierra Leone have been busy fighting the menace created by the deadly Ebola virus, but illicit drug lords have taken advantage of the situation to advance the drug trade. Duration: 01:12 Video provided by AFP
Powered by NewsLook.com
Models in Masks Highlight Indonesian Environmental Devastation

Models in Masks Highlight Indonesian Environmental Devastation

AFP (Mar. 31, 2015) Wearing gas masks and designer dresses, models condemn the fashion industry&apos;s role in causing environmental devastation. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
The Future Of Japanese Whaling: Heritage Vs. Conservation

The Future Of Japanese Whaling: Heritage Vs. Conservation

Newsy (Mar. 30, 2015) In 2014, the International Court of Justice ruled Japan could no longer engage in whaling in the Antarctic, but Japan has plans to return this year. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins